HSD17B13-IN-46
HSD17B13-IN-46 (Compound 351) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) with an IC50 value of [1].
Product Specifications
CAS Number
[2912453-90-6]
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-46.html
Solubility
10 mM in DMSO
Smiles
COC1=C(C=CC(C(O)=O)=C1)NS(=O)(C2=CSC(C3=CC=C(C=C3)C4CCC4)=N2)=O
Molecular Formula
C21H20N2O5S2
Molecular Weight
444.52
References & Citations
[1]Wang G, et al. 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof. U.S. , WO2023023310. 2023-5-11.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
S7972-47-ML490 100 µL
STAT 6, phosphorylated (STAT6B, STAT6C, D12S1644, IL-4-STAT, interleukin 4 induced STAT, Signal Transducer and Activator of Transcription 6) (MaxLight 490)
Ask
View Details 
MBS7019057-01 0.02 mg
Recombinant Human Lipid phosphate phosphatase-related protein type 2 (LPPR2)
Ask
View Details MBS7019057-02 0.1 mg
Recombinant Human Lipid phosphate phosphatase-related protein type 2 (LPPR2)
Ask
View Details MBS7019057-03 5x 0.1 mg
Recombinant Human Lipid phosphate phosphatase-related protein type 2 (LPPR2)
Ask
View Details 